These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12007646)

  • 21. Th1 concomitant immune response mediated by IFN-γ protects against sand fly delivered Leishmania infection: Implications for vaccine design.
    Seyed N; Rafati S
    Cytokine; 2021 Nov; 147():155247. PubMed ID: 32873468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective down-regulation of Th2 immune responses following treatment with antigen-coupled splenocytes.
    Soldera S; McSorley SJ; Glaichenhaus N
    Eur J Immunol; 1997 Apr; 27(4):848-54. PubMed ID: 9130634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.
    Oliveira F; Rowton E; Aslan H; Gomes R; Castrovinci PA; Alvarenga PH; Abdeladhim M; Teixeira C; Meneses C; Kleeman LT; Guimarães-Costa AB; Rowland TE; Gilmore D; Doumbia S; Reed SG; Lawyer PG; Andersen JF; Kamhawi S; Valenzuela JG
    Sci Transl Med; 2015 Jun; 7(290):290ra90. PubMed ID: 26041707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro.
    Theodos CM; Titus RG
    Parasite Immunol; 1993 Aug; 15(8):481-7. PubMed ID: 8233563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite.
    Menon JN; Bretscher PA
    Eur J Immunol; 1998 Dec; 28(12):4020-8. PubMed ID: 9862338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?
    Campos-Neto A
    Braz J Med Biol Res; 2005 Jul; 38(7):979-84. PubMed ID: 16007269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection.
    Onishi K; Li Y; Ishii K; Hisaeda H; Tang L; Duan X; Dainichi T; Maekawa Y; Katunuma N; Himeno K
    Microbes Infect; 2004 Apr; 6(5):468-74. PubMed ID: 15109961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
    Zadeh-Vakili A; Taheri T; Taslimi Y; Doustdari F; Salmanian AH; Rafati S
    Vaccine; 2004 May; 22(15-16):1930-40. PubMed ID: 15121305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
    Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
    Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vector transmission of leishmania abrogates vaccine-induced protective immunity.
    Peters NC; Kimblin N; Secundino N; Kamhawi S; Lawyer P; Sacks DL
    PLoS Pathog; 2009 Jun; 5(6):e1000484. PubMed ID: 19543375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis.
    Sjölander A; Baldwin TM; Curtis JM; Handman E
    J Immunol; 1998 Apr; 160(8):3949-57. PubMed ID: 9558102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sand fly salivary protein acts as a neutrophil chemoattractant.
    Guimaraes-Costa AB; Shannon JP; Waclawiak I; Oliveira J; Meneses C; de Castro W; Wen X; Brzostowski J; Serafim TD; Andersen JF; Hickman HD; Kamhawi S; Valenzuela JG; Oliveira F
    Nat Commun; 2021 May; 12(1):3213. PubMed ID: 34050141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production.
    Hall LR; Titus RG
    J Immunol; 1995 Oct; 155(7):3501-6. PubMed ID: 7561045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulation of immunity to Leishmania major.
    Reiner SL; Locksley RM
    Annu Rev Immunol; 1995; 13():151-77. PubMed ID: 7612219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious diseases. Sand fly saliva may be key to new vaccine.
    Enserink M
    Science; 2001 Aug; 293(5532):1028. PubMed ID: 11498553
    [No Abstract]   [Full Text] [Related]  

  • 37. Sand fly saliva: effects on host immune response and Leishmania transmission.
    Rohousová I; Volf P
    Folia Parasitol (Praha); 2006 Sep; 53(3):161-71. PubMed ID: 17120496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection.
    Morris RV; Shoemaker CB; David JR; Lanzaro GC; Titus RG
    J Immunol; 2001 Nov; 167(9):5226-30. PubMed ID: 11673536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
    Erb KJ; Blank C; Moll H
    Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [LACK protein of Leishmania major: a pivotal antigen in the immune relation between host and parasite].
    Gangneux JP
    Sante; 1997; 7(6):425. PubMed ID: 9503502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.